San Diego, CA (PRWEB) November 04, 2013
Resource4thePeople announced today its latest consumer update involving allegations that interior vena cava (IVC) filters manufactured by C.R. Bard and other manufacturers may cause life-threatening health problems.
Concerns were raised about these devices in a Aug. 9, 2010 health advisory* issued by the U.S. Food and Drug Administration and Resource4thePeople is offering consumers who may have been affected by these allegations free consultations about their rights to seek compensation.
Here is part of the FDA warning:
“Since 2005, the FDA has received 921 device adverse event reports involving IVC filters, of which 328 involved device migration, 146 involved embolizations (detachment of device components), 70 involved perforation of the IVC, and 56 involved filter fracture. Some of these events led to adverse clinical outcomes in patients. These types of events may be related to a retrievable filter remaining in the body for long periods of time, beyond the time when the risk of pulmonary embolism (PE) has subsided.
“The FDA is concerned that these retrievable IVC filters, intended for short-term placement, are not always removed once a patient’s risk for PE subsides. Known long term risks associated with IVC filters include but are not limited to lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.”
Since that warning Resource4thePeople reports that IVC lawsuits have been filed across the country and among the most recent** is one filed by a Texas woman who claims a Bard IVC was defectively designed, failed after being implanted in her body and migrated to her heart.
Copyright©2012 Vocus, Inc.
All rights reserved